Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes.
about
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetesAssociation Between Severe Hypoglycemia and Cardiovascular Disease Risk in Japanese Patients With Type 2 DiabetesThe INITIATOR study: pilot data on real-world clinical and economic outcomes in US patients with type 2 diabetes initiating injectable therapy.Safety and efficacy of the dipeptidyl peptidase-4 inhibitor linagliptin in elderly patients with type 2 diabetes: a comprehensive analysis of data from 1331 individuals aged ≥ 65 years.How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?Dietary restriction and exercise for diabetic patients with chronic kidney disease: a systematic review.Is hypoglycemia fear independently associated with health-related quality of life?Does Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 DiabetesBasal supplementation of insulin lispro protamine suspension versus insulin glargine and detemir for type 2 diabetes: meta-analysis of randomized controlled trialsChanges in Type 2 Diabetes Mellitus Patients in German Primary Care Prior to (2006) and After (2010, 2014) Launch of New DrugsHypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugsReal-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database studyHypoglycemia in Diabetes Mellitus as a Coronary Artery Disease Risk Factor in Patients at Elevated Vascular Risk.Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargine.Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs.Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort studyHypoglycemia associated with hospitalization and adverse events in older people: population-based cohort studyAssociation of self-reported recurrent mild hypoglycemia with incident cardiovascular disease and all-cause mortality in patients with type 2 diabetes: Prospective analysis of the Joint Asia Diabetes Evaluation Registry.Do we still need pioglitazone for the treatment of type 2 diabetes? A risk-benefit critique in 2013.A Link Between Hypoglycemia and Progression of Atherosclerosis in the Veterans Affairs Diabetes Trial (VADT).Hypoglycemia as a driver of cardiovascular risk in diabetesCombination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality.Regardless of the degree of glycaemic control, linagliptin has lower hypoglycaemia risk than all doses of glimepiride, at all time points, over the course of a 2-year trial.Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis.The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes.Hypoglycaemia, thrombosis and vascular events in diabetes.Patient Understanding of Hypoglycemia in Tertiary Referral Centers.Hypoglycaemia in diabetes: do we think enough of the cause? An observational study on prevalence and causes of hypoglycaemia among patients with type 2 diabetes in an out-patient setting in Sri Lanka.
P2860
Q26827955-C5098BC7-F69F-461A-8425-30CDED65654EQ28073762-DE517543-A0D2-4764-A062-496F5F0F9A72Q30705030-1ACCACB6-3F39-4956-A793-B0BED237B9D5Q30827022-978B6031-52A2-4D52-85C6-6215E8DB402CQ33727447-E28E5698-E09B-4102-A314-05B23AD453CDQ34572119-E337E06E-085E-4891-A482-C632D6D40F8FQ34720760-3863D67A-5F64-4717-B579-6BD1B4DFAE31Q35679023-1057E269-F7A5-40B1-96BB-AE0EDEF0378BQ36426817-4CAD5085-093A-49F9-918F-8341E5714125Q36638899-1CDF56AA-4FEF-438E-B632-D74F8CE1EC61Q36670946-985B42DE-36E5-451C-8A45-B3C258DAB69AQ36809906-1124E0D1-C48B-454C-94C6-1629221AF6CBQ36935362-95325266-FBC8-4E9E-A119-A2084D6098B9Q37207121-306BA9D6-55B4-46F9-AC55-51BFB4A822ECQ37225390-E0C0EAAA-DFB2-4EBF-96AA-CC3292BD2FF8Q37271600-B0F3EE05-A61A-43DD-AD5D-6D6CE6CD4066Q37278169-F446C1B5-EA8A-41D2-B7AF-1D799E16BF21Q37409531-97A5F810-1566-4FED-B8E0-C23B9D1F4C38Q37577159-0B20E264-D54C-4EF0-96B2-7B959A5C4404Q37652806-0ECE8DBC-558B-4B78-87AE-C0345D0CE608Q38123733-7CB56842-0FB3-4699-818D-ED9BC65BCF8AQ43651118-63ECE1A9-CF44-4439-9968-1394E9BB79ABQ44127740-F896AC31-11A9-4FFE-A2F7-AC9B2455E851Q47305063-05FE9EEF-BCED-4CC2-87F3-EBEF700DCB99Q47615333-FB5D1A48-690D-45ED-B251-5DE88BBEAD27Q52815156-AAC6B92B-A794-4B31-884F-0D213B80561EQ53441676-F7D4BC80-5638-4B79-8D5C-0F0A22EBC415Q55476876-367B9BCF-3728-4AE6-BF22-ACACACB73698
P2860
Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Impact of hypoglycemia associa ...... veterans with type 2 diabetes.
@ast
Impact of hypoglycemia associa ...... veterans with type 2 diabetes.
@en
type
label
Impact of hypoglycemia associa ...... veterans with type 2 diabetes.
@ast
Impact of hypoglycemia associa ...... veterans with type 2 diabetes.
@en
prefLabel
Impact of hypoglycemia associa ...... veterans with type 2 diabetes.
@ast
Impact of hypoglycemia associa ...... veterans with type 2 diabetes.
@en
P2093
P2860
P921
P356
P1433
P1476
Impact of hypoglycemia associa ...... veterans with type 2 diabetes.
@en
P2093
Claudia R Campbell
Lizheng Shi
Vivian Fonseca
Yingnan Zhao
P2860
P304
P356
10.2337/DC11-2048
P407
P577
2012-03-19T00:00:00Z